Activity and safety of lenalidomide and dexamethasone in patients with multiple myeloma requiring dialysis: a Spanish multicenter retrospective study

被引：28
|
作者：
de la Rubia, Javier [1 ,2 ]
Roig, Monica [1 ]
Ibanez, Angela [3 ]
Garcia, Inmaculada [5 ]
Vera, Jose A. [4 ]
Aguilar, Carlos [6 ]
del Campo, Raquel [7 ]
Gonzalez, Nicolas [8 ]
Martinez, Rafael [9 ]
Palomera, Luis [10 ]
Picon, Isabel [11 ]
Rodriguez, Juan N. [12 ]
Sanz, Miguel A. [1 ]
机构：
[1] Hosp La Fe, E-46009 Valencia, Spain
[2] Univ Catolica San Vicente Martir, Valencia, Spain
[3] Gen Hosp, Albacete, Spain
[4] Hosp Virgen Macarena, Seville, Spain
[5] Gen Hosp, Castellon de La Plana, Spain
[6] Hosp Santa Barbara, Soria, Spain
[7] Hosp Son Llatzer, Palma de Mallorca, Spain
[8] Hosp Gen Obispo Polanco, Teruel, Spain
[9] Hosp Clin San Carlos, Madrid, Spain
[10] Hosp Lozano Blesa, Zaragoza, Spain
[11] Inst Valenciano Oncol, Valencia, Spain
[12] Hosp Juan Ramon Jimenez, Huelva, Spain
来源：
EUROPEAN JOURNAL OF HAEMATOLOGY | 2010年 / 85卷 / 04期
关键词：
RENAL-FAILURE; PLUS DEXAMETHASONE; THALIDOMIDE; COMBINATION; THERAPY;
D O I：
10.1111/j.1600-0609.2010.01500.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：363 / 365
页数：3
相关论文
共 50 条
  • [1] Activity and Safety of Lenalidomide and Dexamethasone in Multiple Myeloma Patients with Advanced Renal Failure: a Spanish Multicenter Retrospective Study.
    Roig, Monica
    Ibanez, Angela
    Garcia, Inmaculada
    Vera, Juan A.
    Aguilar, Carlos
    del Campo, Raquel
    Gonzalez, Nicolas
    Martinez, Rafael
    Palomera, Luis
    Picon, Isabel
    Rodriguez, Jose N.
    Sanz, Miguel A.
    de la Rubia, Javier
    BLOOD, 2009, 114 (22) : 749 - 749
  • [2] Activity and Safety of Daratumumab Monotheray in Patients with Relapsed and Refractory Multiple Myeloma Requiring Dialysis: Preliminary Results of Spanish, Retrospective, Multicenter Trial
    Cejalvo, Maria Jose
    Legarda, Mario
    Abella, Eugenia
    Cabezudo, Elena
    Encinas, Cristina
    Garcia-Feria, Ana
    Inigo, Belen
    Marin, Jesus
    Ribas, Paz
    Ruiz, M. Angeles
    de la Rubia, Javier
    BLOOD, 2017, 130
  • [3] Outcomes of ixazomib/lenalidomide/dexamethasone for multiple myeloma: A multicenter retrospective analysis
    Takakuwa, Teruhito
    Yamamura, Ryosuke
    Ohta, Kensuke
    Kaneko, Hitomi
    Imada, Kazunori
    Nakaya, Aya
    Fuchida, Shin-ichi
    Shibayama, Hirohiko
    Matsuda, Mitsuhiro
    Shimazu, Yutaka
    Adachi, Yoko
    Kosugi, Satoru
    Uchiyama, Hitoji
    Tanaka, Hirokazu
    Hanamoto, Hitoshi
    Shimura, Yuji
    Kanda, Junya
    Onda, Yoshiyuki
    Uoshima, Nobuhiko
    Yagi, Hideo
    Yoshihara, Satoshi
    Hino, Masayuki
    Shimazaki, Chihiro
    Takaori-Kondo, Akifumi
    Kuroda, Junya
    Matsumura, Itaru
    Kanakura, Yuzuru
    Nomura, Shosaku
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 106 (04) : 555 - 562
  • [4] Efficacy and safety of lenalidomide and dexamethasone in overtreated multiple myeloma patients.
    Moscetti, Alessandro
    Resci, Federica
    Antolino, Giusy
    Saltarelli, Francesca
    Monarca, Bruno
    Bianchi, Maria Paola
    Naso, Virginia
    De Benedittis, Daniela
    La Verde, Giacinto
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [5] Safety, Efficacy, and Quality-of-Life Study of Lenalidomide Phis Dexamethasone in Previously Treated Patients with Multiple Myeloma: The Spanish Experience
    Alegre, Adrian
    Oriol-Rocafiguera, Albert
    Garcia-Larana, Jose
    Mateos, Maria-Victoria
    Sureda, Anna
    Martinez Chamorro, Carmen
    Teresa Cibeira, Maria
    Knight, Robert
    Rosettani, Barbara
    BLOOD, 2010, 116 (21) : 1255 - 1255
  • [6] Activity and safety of bortezomib in multiple myeloma patients with advanced renal failure: a multicenter retrospective study
    Chanan-Khan, Asher A.
    Kaufman, Jonathan L.
    Mehta, Jayesh
    Richardson, Paul G.
    Miller, Kena C.
    Lonial, Sagar
    Munshi, Nikhil C.
    Schlossman, Robert
    Tariman, Joseph
    Singhal, Seema
    BLOOD, 2007, 109 (06) : 2604 - 2606
  • [7] Single-agent daratumumab in patients with relapsed and refractory multiple myeloma requiring dialysis: results of a Spanish retrospective, multicentre study
    Cejalvo, Maria J.
    Legarda, Mario
    Abella, Eugenia
    Cabezudo, Elena
    Encinas, Cristina
    Garcia-Feria, Ana
    Gironella, Mercedes
    Inigo, Belen
    Martin, Jesus
    Ribas, Paz
    Angeles Ruiz, Ma
    Gonzalez, Yolanda
    Vicuna, Isabel
    Ramirez, Angel
    Fernandez, Pascual
    de la Rubia, Javier
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 190 (05) : E289 - E292
  • [8] Bortezomib, lenalidomide, and dexamethasone in transplant-eligible newly diagnosed multiple myeloma patients: a multicenter retrospective comparative analysis
    Kazuhito Suzuki
    Nobuhiro Tsukada
    Noriko Nishimura
    Yasuyuki Nagata
    Kiyoshi Okazuka
    Yuko Mishima
    Masahiro Yokoyama
    Kaichi Nishiwaki
    Tadao Ishida
    Shingo Yano
    Yasuhito Terui
    Kenshi Suzuki
    International Journal of Hematology, 2020, 111 : 103 - 111
  • [9] Bortezomib, lenalidomide, and dexamethasone in transplant-eligible newly diagnosed multiple myeloma patients: a multicenter retrospective comparative analysis
    Suzuki, Kazuhito
    Tsukada, Nobuhiro
    Nishimura, Noriko
    Nagata, Yasuyuki
    Okazuka, Kiyoshi
    Mishima, Yuko
    Yokoyama, Masahiro
    Nishiwaki, Kaichi
    Ishida, Tadao
    Yano, Shingo
    Terui, Yasuhito
    Suzuki, Kenshi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 111 (01) : 103 - 111
  • [10] Opposing Effects of Dexamethasone on Lenalidomide Activity in Multiple Myeloma
    Schafer, P. H.
    Gandhi, A. K.
    Zhang, L. H.
    Kang, J.
    Capone, L.
    Parton, S.
    Wu, L.
    Bartlett, B.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S135 - S135
12345